Epidemiology of prostate cancer: International variation
Hinotsu, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 3: 34-38
2016
ISSN/ISBN: 0047-1852 PMID: 27344699 Document Number: 690483
Document emailed within 1 workday
Related Documents
O'Sullivan, E.M. 2008: International variation in the incidence of oral and pharyngeal cancer Community Dental Health 25(3): 148-153Rébillard, X.; Tretarre, B.; Villers, A. 2003: The epidemiology of prostate cancer La Revue du Praticien 53(20): 2224-2228
Hinotsu, S. 2011: An international comparison of epidemiologic factors of prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl. 5: 187-192
Pienta, K.J. 1994: The epidemiology of prostate cancer: clues for chemoprevention In Vivo 8(3): 419-422
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Sarma, A.V.; Schottenfeld, D. 2002: Projecting prostate cancer incidence and mortality trends using the Surveillance, Epidemiology and End Results data American Journal of Epidemiology 155(11 Suppl): S15
Drake, B.F.; Keane, T.E.; Mosley, C.M.; Adams, S.Arp.; Elder, K.T.; Modayil, M.V.; Ureda, J.R.; Hebert, J.R. 2006: Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology Journal of the South Carolina Medical Association 102(7): 241-249
2016: Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC) Clinical Advances in Hematology and Oncology: H&o 14(4 Suppl. 5): 10-11
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Tricco, A.C.; Tugwell, P.; Knottnerus, J.André. 2015: The International Clinical Epidemiology Network increases capacity for clinical epidemiology research in Jamaica Journal of Clinical Epidemiology 68(9): 967-969
Zhu, X-Dong.; Zheng, A.; Wang, Z-Qian.; Shao, Q. 2018: Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population Zhonghua Nan Ke Xue 24(2): 142-146